Strides Pharma Scien - Quarterly Results
29th Jul 2022

The sales is pegged at Rs. 4231.90 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 5087.90 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -662.54 millions as compared to Net Loss of Rs. -212.31 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -535.67% as compared to 169.36% of corresponding quarter ended June 2021



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4231.90 5087.90 -16.82 4231.90 5087.90 -16.82 19790.03 18575.66 6.54
Other Income 74.65 116.86 -36.12 74.65 116.86 -36.12 1234.85 889.96 38.75
PBIDT -535.67 169.36 -416.29 -535.67 169.36 -416.29 2001.15 2763.16 -27.58
Interest 260.17 180.91 43.81 260.17 180.91 43.81 742.41 653.39 13.62
PBDT -795.84 -11.55 6790.39 -795.84 -11.55 6790.39 1258.74 2109.77 -40.34
Depreciation 242.96 266.36 -8.79 242.96 266.36 -8.79 1043.66 993.42 5.06
PBT -1038.80 -277.91 273.79 -1038.80 -277.91 273.79 215.08 1116.35 -80.73
TAX -376.26 -65.60 473.57 -376.26 -65.60 473.57 -1586.80 333.95 -575.16
Deferred Tax -376.26 -65.60 473.57 -376.26 -65.60 473.57 -2.09 123.77 -101.69
PAT -662.54 -212.31 212.06 -662.54 -212.31 212.06 1801.88 782.40 130.30
Equity 898.04 897.17 0.10 898.04 897.17 0.10 897.90 896.80 0.12
PBIDTM(%) -12.66 3.33 -480.27 -12.66 3.33 -480.27 10.11 14.88 -32.02